H1202 • 2025

An Act establishing a commission to study maximum allowable costs lists

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor: Bradley H. Jones, Jr.
Last action: 2026-03-12
Official status: Accompanied a study order, see H5223
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act establishing a commission to study maximum allowable costs lists

An Act establishing a commission to study maximum allowable costs lists By Representative Jones of North Reading, a petition (accompanied by bill, House, No.

What This Bill Does

An Act establishing a commission to study maximum allowable costs lists By Representative Jones of North Reading, a petition (accompanied by bill, House, No.
1202) of Bradley H.
Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to maximum allowable costs lists utilized by payers and pharmaceutical benefit managers to identify the maximum amount health plans will pay for certain prescription drugs.
Financial Services.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2026-03-12 House
Accompanied a study order, see H5223
2025-10-01 Joint
Hearing rescheduled to 10/01/2025 from 10:30 AM-11:20 PM in B-1 and Virtual Hearing updated to New End Time
2025-10-01 Joint
Hearing scheduled for 10/01/2025 from 10:30 AM-01:00 PM in B-1
2025-09-29 Joint
Hearing rescheduled to 10/01/2025 from 10:30 AM-01:00 PM in B-1 and Virtual Hearing location changed
2025-09-25 Joint
Hearing rescheduled to 10/01/2025 from 10:30 AM-01:00 PM in A-1 and Virtual Hearing location changed
2025-09-19 Joint
Hearing scheduled for 10/01/2025 from 10:30 AM-01:00 PM in B-2
2025-02-27 House
Referred to the committee on Financial Services
2025-02-27 Senate
Senate concurred

Official Summary Text

An Act establishing a commission to study maximum allowable costs lists
By Representative Jones of North Reading, a petition (accompanied by bill, House, No. 1202) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to maximum allowable costs lists utilized by payers and pharmaceutical benefit managers to identify the maximum amount health plans will pay for certain prescription drugs. Financial Services.

Current Bill Text

Read the full stored bill text

×

Bill H.1202

Notwithstanding any general or special law to the contrary, there shall be a special commission established to investigate the use of maximum allowable costs lists, utilized by payers and pharmaceutical benefit managers to identify the maximum amount that a plan will pay for various prescription drugs. The commission’s review shall include, but not be limited to, current practices surrounding the determination and use of maximum allowable costs lists and their financial implications; industry-wide standardization for the development and use of maximum allowable costs lists; and transparency into the processes of developing and utilizing maximum allowable costs lists.

The commission shall consist of 10 members: the secretary of health and human services, or a designee, who shall serve as the chair; the speaker of the house of representatives, or a designee; the senate president, or a designee; the minority leader of the house of representatives, or a designee; the minority leader of the senate, or a designee; a representative from the Massachusetts Association of Health Plans; a representative from the Massachusetts Pharmacists Association; one person who shall be an advocate for health care providers, to be appointed by the governor; one person who shall be an advocate for pharmaceutical companies, to be appointed by the governor; and one person who shall be an advocate for pharmaceutical benefit managers, to be appointed by the governor.

The commission shall submit its report and findings, along with any draft of legislation, to the house and senate committees on ways and means, the joint committee on health care financing, and the clerks of the house of representatives and the senate within 180 days of the passage of this act.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close